Drugs for Neglected Diseases Initiative
The Drugs for Neglected Diseases initiative is a collaborative, patients' needs-driven, non-profit drug research and development organization that is developing new treatments for neglected diseases, notably leishmaniasis, sleeping sickness, Chagas disease, malaria, filarial diseases, mycetoma, paediatric HIV, cryptococcal meningitis, hepatitis C, and dengue. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Drugs for Neglected Diseases Initiative, Switzerland, covering academic research published from 2003 to 2023. Read More.
Open Access Percentage
84%
Total
Publications
685
Total Open
Publications
577
Total
Citations
27K
Open Access
Percentage
84%
Total
Publications
685
Total Open
Publications
577
Total
Citations
27K
Breakdown
Publisher Open
10%
Both
63%
Other Platform Open
11%
Closed
16%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 60%
297
Hybrid 29%
146
No Guarantees 11%
56
Other Platform Open
Domain 82%
419
Institution 49%
251
Public 14%
74
Other Internet 13%
69
Preprint 10%
51
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 418 |
Europe PMC | Domain | 259 |
Semantic Scholar | Public | 57 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 39 |
University College London - UCL Discovery | Institution | 38 |
London School of Hygiene and Tropical Medicine - LSHTM Research Online | Institution | 37 |
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia | Other Internet | 34 |
lshtm.ac.uk OAI-PMH Repository | Institution | 30 |
DOI | Other Internet | 22 |
Erasmus University Rotterdam - EUR Research Repository | Institution | 21 |